Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
(ENTX) MC $29 M about to EXPLODEEE ..Important Phase 2 data IMMINENT a potential Blockbuster / Price $1.54 ...
? Completed Enrollment in Phase 2 Clinical Trial of EB613, Positioned as the First Potential Oral Bone Building Product to Treat Osteoporosis ?
? Positive Interim 6-Month Bone Mineral Density (BMD) Data Reported in Phase 2 EB613 Clinical Trial ?
? Company Expects to Report Biomarker Data that Includes the 2.5 mg Dose in Q1:21 and Final Data from The Phase 2 Trial Including BMD in Q2:21 ?
(ENTX) MC $29 M about to EXPLODEEE ..Important Phase 2 data IMMINENT a potential Blockbuster / Price $1.54 ...
? Completed Enrollment in Phase 2 Clinical Trial of EB613, Positioned as the First Potential Oral Bone Building Product to Treat Osteoporosis ?
? Positive Interim 6-Month Bone Mineral Density (BMD) Data Reported in Phase 2 EB613 Clinical Trial ?
? Company Expects to Report Biomarker Data that Includes the 2.5 mg Dose in Q1:21 and Final Data from The Phase 2 Trial Including BMD in Q2:21 ?
(ADTX) EUA APPROVAL IMMINENT ..starts moving potential tenbagger
(ADTX) EUA APPROVAL IMMINENT ..starts moving potential tenbagger
(AMTX)EV stock EXPLODINNGGGGG Price $2.79 / MCap $61 million / MOST CHEAPEST EV company ..could run like BLNK or PLUG did ...
AMTX Stock: 10 Things for Aemetis Investors to Know About the Nevo Motors Deal
https://investorplace.com/2020/12/amtx-stock-10-things-for-aemetis-investors-to-know-about-the-nevo-motors-deal/
(AMTX)EV stock EXPLODINNGGGGG Price $2.79 / MCap $61 million / MOST CHEAPEST EV company ..could run like BLNK or PLUG did ...
AMTX Stock: 10 Things for Aemetis Investors to Know About the Nevo Motors Deal
https://investorplace.com/2020/12/amtx-stock-10-things-for-aemetis-investors-to-know-about-the-nevo-motors-deal/
(ACER) MC $31 M-Covid 19 Data IMMINENT--Another 2 Drug in Phase 3 with first readout expected next Quarter ..this low floater could double or more within 1 day on positive coid data .GLTA
(ACER) MC $31 M-Covid 19 Data IMMINENT--Another 2 Drug in Phase 3 with first readout expected next Quarter ..this low floater could double or more within 1 day on positive coid data .GLTA
(DXR) FLOAT 1 M --HOT COVID GEM...UNDISCOVERED low float sleeping giant
THIRD HOSPITAL JOINS MULTICENTER COVID-19 BVA-100® BLOOD TEST STUDY
https://finance.yahoo.com/news/third-hospital-joins-multicenter-covid-133000025.html
(DXR) FLOAT 1 M --HOT COVID GEM...UNDISCOVERED low float sleeping giant
THIRD HOSPITAL JOINS MULTICENTER COVID-19 BVA-100® BLOOD TEST STUDY
https://finance.yahoo.com/news/third-hospital-joins-multicenter-covid-133000025.html
CYTH - unknown stock BREEEEEEEEEEEEEAAAAAAAK OUUUUUUUUUUUUT IMMINENT
MC $16 M-PHASE 3 Blockbuster Drug ,Only 4.2 M Outstanding shares, NEW nasdaq Stock and still undiscovered .This one could explode like a nuclear bomb on news .GLTA
CYTH - unknown stock BREEEEEEEEEEEEEAAAAAAAK OUUUUUUUUUUUUT IMMINENT
MC $16 M-PHASE 3 Blockbuster Drug ,Only 4.2 M Outstanding shares, NEW nasdaq Stock and still undiscovered .This one could explode like a nuclear bomb on news .GLTA
ACER =MC $29M--COVID 19 DATA IMMINENT low float gem
ACER =MCap $29 M --2x BIG Phase 3 Drugs + results from Covid 19 Program expected THIS Q / UNDISCOVERED stock
ACER = MC $29M--COVID 19 DATA IMMINENT low float gem
ACER =MCap $29 M --2x BIG Phase 3 Drugs + results from Covid 19 Program expected THIS Q / UNDISCOVERED stock
ADTX = BREEEEEEEEEEEEEEEEEEEEEAAAAAAAK OUUUUUUUUUUUUUT IMMINENT, infos below:
MC $25 M EUA approval IMMINENT for Covid 19 product
"AditxtScore™ for COVID-19, for use in detecting antibodies against SARS-CoV-2 antigens, and for which we are awaiting a response from the U.S. Food and Drug Administration regarding the Emergency Use Authorization (EUA) application that we filed in August. As we’ve announced, we’re working hard to position the Company for commercialization of this product."
ADTX = BREEEEEEEEEEEEEEEEEEEEEAAAAAAAK OUUUUUUUUUUUUUT IMMINENT, infos below:
MC $25 M EUA approval IMMINENT for Covid 19 product
"AditxtScore™ for COVID-19, for use in detecting antibodies against SARS-CoV-2 antigens, and for which we are awaiting a response from the U.S. Food and Drug Administration regarding the Emergency Use Authorization (EUA) application that we filed in August. As we’ve announced, we’re working hard to position the Company for commercialization of this product."
(ADOM) - RAAAAAAAAAAAAAAAAALLLLLLLLLLLLLYYYYYYYYYY
Price 0.24--CHEAPEST EV Gem start running could be a 10++bagger stock ..Brutally underpriced at 17 million valuation
https://adomanielectric.com/products/
(ADOM) - RAAAAAAAAAAAAAAAAALLLLLLLLLLLLLYYYYYYYYYY
Price 0.24--CHEAPEST EV Gem start running could be a 10++bagger stock ..Brutally underpriced at 17 million valuation
https://adomanielectric.com/products/
WAVE.V =MC $8 M /2 MEGA CANCER Drug Approvals IMMINENT in Q4 for the US and European markets . Company has already 5x APPROVED Cancer Drugs for EU markets 2 of them jsut approved in last 2 weeks . This COMPLETE unknown Company is close to profitability . This stock is what i call A ONCE in A LIFETIME OPP guys market cap of C$ 8 million is more than just a PURE GIFT .
Waverley Pharma (WAVE.V) canadian company
Waverley Pharma Announces Grant of Market Authorization of Pemetrexed and Bortezomib in Multiple European Countries.. July 30, 2020
https://www.waverleypharma.com/uploads/3/8/0/2/38024367/waverley_pharma_-_press_release_-_july_30_2020.pdf
Pipeline
https://www.waverleypharma.com/generic-product-pipeline.html
WAV-101 is an injectable generic chemotherapy drug development for the treatment of non-small cell lung cancer and other indications. Currently there is no marketed generic version for this product in the United States, and the brand generates yearly revenue of over $1 billion USD. Since regulatory filings have been made in the United States and Europe, Waverley Pharma is seeking a sales and marketing partner for Europe.
WAV-102 is an injectable generic chemotherapy drug developed for the treatment of multiple myeloma and other indications. Currently there is no marketed generic for this product and the brand generates yearly revenue of over $800 million USD. Since regulatory filings have been made in the United States and Europe, Waverley Pharma is seeking a sales and marketing partner for Europe.
WAVE.V =MC $8 M /2 MEGA CANCER Drug Approvals IMMINENT in Q4 for the US and European markets . Company has already 5x APPROVED Cancer Drugs for EU markets 2 of them jsut approved in last 2 weeks . This COMPLETE unknown Company is close to profitability . This stock is what i call A ONCE in A LIFETIME OPP guys market cap of C$ 8 million is more than just a PURE GIFT .
Waverley Pharma (WAVE.V) canadian company
Waverley Pharma Announces Grant of Market Authorization of Pemetrexed and Bortezomib in Multiple European Countries.. July 30, 2020
https://www.waverleypharma.com/uploads/3/8/0/2/38024367/waverley_pharma_-_press_release_-_july_30_2020.pdf
Pipeline
https://www.waverleypharma.com/generic-product-pipeline.html
WAV-101 is an injectable generic chemotherapy drug development for the treatment of non-small cell lung cancer and other indications. Currently there is no marketed generic version for this product in the United States, and the brand generates yearly revenue of over $1 billion USD. Since regulatory filings have been made in the United States and Europe, Waverley Pharma is seeking a sales and marketing partner for Europe.
WAV-102 is an injectable generic chemotherapy drug developed for the treatment of multiple myeloma and other indications. Currently there is no marketed generic for this product and the brand generates yearly revenue of over $800 million USD. Since regulatory filings have been made in the United States and Europe, Waverley Pharma is seeking a sales and marketing partner for Europe.
TMBR = BREEEEEEEEEEAAAAAK OUUUUUUUUUT IMMINENT
MC $25 M / Cash $25 M / MEGA Product Pipeline / Float 2 M / NEW Nasdaq stock = 1000% Upside potential and even then it would be still attractive .GL
TMBR = BREEEEEEEEEEAAAAAK OUUUUUUUUUT IMMINENT
MC $25 M / Cash $25 M / MEGA Product Pipeline / Float 2 M / NEW Nasdaq stock = 1000% Upside potential and even then it would be still attractive .GL
KBSF =MC $6 M /Face Mask /Cash $20M /Book Value $21 per share / Shares Out 2.6 M = the MOST underpriced and undiscovred low float corona gem i ever have seen
KBSF =MC $6 M /Face Mask /Cash $20M /Book Value $21 per share / Shares Out 2.6 M = the MOST underpriced and undiscovred low float corona gem i ever have seen
AYRO = MC$38 M/NextTESLA? Next BILLION $ Company according to Ceo in the Video below ..NEW nasdaq Stock ..Low float gem
https://secure.preipobuzz.com/ev-spotlight/?utm_campaign=EVSpotlight&utm_medium=Manychat&utm_source=PIPO&mcp_token=eyJwaWQiOjE1NTg1NzI2NTI2NTMxOSwic2lkIjoyMTU3Mjk2MzI0Mzc3MjcxLCJheCI6IjEzZjk3OWM5MTk4MzdkMTNhNzQyODkyOWZkMjllNjMzIiwidHMiOjE1OTE2NDI3NDQsImV4cCI6MTU5NDA2MTk0NH0.6ab2Hpdu11Q0d2QjUlvAwdHeYfKgFmcZQRFrsKQy3mE
AYRO = MC$38 M/NextTESLA? Next BILLION $ Company according to Ceo in the Video below ..NEW nasdaq Stock ..Low float gem
https://secure.preipobuzz.com/ev-spotlight/?utm_campaign=EVSpotlight&utm_medium=Manychat&utm_source=PIPO&mcp_token=eyJwaWQiOjE1NTg1NzI2NTI2NTMxOSwic2lkIjoyMTU3Mjk2MzI0Mzc3MjcxLCJheCI6IjEzZjk3OWM5MTk4MzdkMTNhNzQyODkyOWZkMjllNjMzIiwidHMiOjE1OTE2NDI3NDQsImV4cCI6MTU5NDA2MTk0NH0.6ab2Hpdu11Q0d2QjUlvAwdHeYfKgFmcZQRFrsKQy3mE
AYRO = BREEEEEEAAAAAK OUUUT IMMINENT
MC$38 M/NextTESLA? Next BILLION $ Company according to Ceo in the Video below ..NEW nasdaq Stock ..Low float gem
https://secure.preipobuzz.com/ev-spotlight/?utm_campaign=EVSpotlight&utm_medium=Manychat&utm_source=PIPO&mcp_token=eyJwaWQiOjE1NTg1NzI2NTI2NTMxOSwic2lkIjoyMTU3Mjk2MzI0Mzc3MjcxLCJheCI6IjEzZjk3OWM5MTk4MzdkMTNhNzQyODkyOWZkMjllNjMzIiwidHMiOjE1OTE2NDI3NDQsImV4cCI6MTU5NDA2MTk0NH0.6ab2Hpdu11Q0d2QjUlvAwdHeYfKgFmcZQRFrsKQy3mE
AYRO = MCap $38 M/ NEXT TESLA ? A MONSTER OPP
(AYRO) Market Cap $38 Million / Shares Out 12.5 M / manufactures and already starts selling electric vehicles / COMPLETELY UNKNOWN COMPANY which went Pulic a few days ago = Undiscovered and MOST CHEAPEST EV maker out there could be a MEGA LIFETIME OPP like TSLA was at $20 in 2011 .STRONG BUY SUPER DUPA AGGRESSIVE and GL
Ayro Inc (AYRO)
Markt-Cap: $38 million
Price: $3
Shares Out: 12.5
Video Presentation and more infos (Watch It)
https://secure.ayro.com/merger/?main-site-popup
AYRO Along With Strategic Partner, Club Car, Expand Into Higher-Ed Market at Princeton and Penn State
https://www.businesswire.com/news/home/20200331005163/en/AYRO-Strategic-Partner-Club-Car-Expand-Higher-Ed
According to the Association for the Advancement of Sustainability in Higher Education (ASSHE), there are over 1,800 colleges and universities in the U.S. that have fleets of at least 400 vehicles. This represents a base of over 535,000 vehicles that are in need of converting over from gas-powered vehicles to electric vehicles. With an average conversion price of $14,000, this represents a potential market of more than $7 billion.
AYRO, Inc., a designer and manufacturer of purpose-built compact, light-duty emissions-free electric vehicles for urban, commercial, consumer and government markets, announces the Company’s first vehicle deliveries of its Club Car 411 to Canada and Mexico through its strategic partnership with Club Car, Inc. ("Club Car").
https://finance.yahoo.com/news/ayro-club-car-partnership-announce-130000175.html
AYRO, Inc. (AYRO), is a designer and manufacturer of purpose-built, automotive-grade electric vehicles (EV). The Company´s EV models include AYRO 311 and Club Car 411. AYRO 311 is a three-wheeled vehicle with inline seating and four-door access for professional and personal use. The Company offers its AYRO 311 with multiple configurations including fully enclosed two-seater, half doors and one-seater with the cargo area. The Club Car 411 is a compact all-electric vehicle suitable for low-speed logistics and cargo services. The Company offers Club Car 411 with multiple bed configurations including a fully enclosed box truck, pickup bed and flatbed. AYRO delivers electric vehicle solutions for campus management, last-mile delivery, urban commuting and closed campus transport.
AYRO = MCap $38 M/ NEXT TESLA ? A MONSTER OPP
(AYRO) Market Cap $38 Million / Shares Out 12.5 M / manufactures and already starts selling electric vehicles / COMPLETELY UNKNOWN COMPANY which went Pulic a few days ago = Undiscovered and MOST CHEAPEST EV maker out there could be a MEGA LIFETIME OPP like TSLA was at $20 in 2011 .STRONG BUY SUPER DUPA AGGRESSIVE and GL
Ayro Inc (AYRO)
Markt-Cap: $38 million
Price: $3
Shares Out: 12.5
Video Presentation and more infos (Watch It)
https://secure.ayro.com/merger/?main-site-popup
AYRO Along With Strategic Partner, Club Car, Expand Into Higher-Ed Market at Princeton and Penn State
https://www.businesswire.com/news/home/20200331005163/en/AYRO-Strategic-Partner-Club-Car-Expand-Higher-Ed
According to the Association for the Advancement of Sustainability in Higher Education (ASSHE), there are over 1,800 colleges and universities in the U.S. that have fleets of at least 400 vehicles. This represents a base of over 535,000 vehicles that are in need of converting over from gas-powered vehicles to electric vehicles. With an average conversion price of $14,000, this represents a potential market of more than $7 billion.
AYRO, Inc., a designer and manufacturer of purpose-built compact, light-duty emissions-free electric vehicles for urban, commercial, consumer and government markets, announces the Company’s first vehicle deliveries of its Club Car 411 to Canada and Mexico through its strategic partnership with Club Car, Inc. ("Club Car").
https://finance.yahoo.com/news/ayro-club-car-partnership-announce-130000175.html
AYRO, Inc. (AYRO), is a designer and manufacturer of purpose-built, automotive-grade electric vehicles (EV). The Company´s EV models include AYRO 311 and Club Car 411. AYRO 311 is a three-wheeled vehicle with inline seating and four-door access for professional and personal use. The Company offers its AYRO 311 with multiple configurations including fully enclosed two-seater, half doors and one-seater with the cargo area. The Club Car 411 is a compact all-electric vehicle suitable for low-speed logistics and cargo services. The Company offers Club Car 411 with multiple bed configurations including a fully enclosed box truck, pickup bed and flatbed. AYRO delivers electric vehicle solutions for campus management, last-mile delivery, urban commuting and closed campus transport.
(AYRO) RUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUNIIIIIIIING
MC $39 Mil /Next TESLA ? company is NEW on Nasdaq since a few days and they already starts selling ELECTRIC Cars =could be a MEGA Opportunity here guys
Video Presentation and more infos (Watch It)
https://secure.ayro.com/merger/?main-site-popup
(AYRO) RUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUUNIIIIIIIING
MC $39 Mil /Next TESLA ? company is NEW on Nasdaq since a few days and they already starts selling ELECTRIC Cars =could be a MEGA Opportunity here guys
Video Presentation and more infos (Watch It)
https://secure.ayro.com/merger/?main-site-popup
EVFM - REEEEEEEEEEEEEEEEEEEEEEEEEBOUND back to 5$ could start anytime now - closing of the offering most probably today. GL
DRAD = BREEEEEEEEEEEEEEEEEEEEEEEEEEEAAAAAAAAAAAAAAAAAAAAK OUUUUUUUUUUUUUUUUUT imminent
market cap only $10 million / float 1.7 million / book value at $8.65 PER SHARE
DRAD =RUNNINGGGGG market cap only $10 million / float 1.7 million / book value at $8.65 PER SHARE
ETON = NEEEEEEEEEEEEEEEXT BIIIIIIIIG LEG UP TODAY?
MC $96 M /3x FDA DECISIONS in this year (link below) /LOW FLOAT =CHEAPEST and MOST attractive FDA Gem in 2020
ETON = NEEEEEEEEEEEEEEEXT BIIIIIIIIG LEG UP TODAY?
MC $96 M /3x FDA DECISIONS in this year (link below) /LOW FLOAT =CHEAPEST and MOST attractive FDA Gem in 2020
(ETON) BREEEEEEEEEEEEEEEEEEEEEEEEEEEAAAAAAAAAAAAAAK OUUUUUUUUUUUUUUUUUUUUUUUUUT
3x FDA DECISIONS running higher ..could run to $8 even ahead of the first FDA deicison in early August ..
(ETON) BREEEEEEEEEEEEEEEEEEAAAAAK OUUUUUUUUUUUUUUUUUUUUUUUT
3x FDA DECISIONS running higher ..could run to $8 even ahead of the first FDA deicison in early August ..
ETON = BREEEEEEEEEEEEEEEEEEEEEAAAAAAAAAAAAAAAAAAAAK OUUUUUUUUUUUUUUUUUUUT
MC $96 M--3x FDA DECISIONS this year including a Orphan Drug ,LOW FLOAT =CHEAPEST and MOST attractive FDA Gem in 2020 a potential 10 Bagger . Could run to 8$ even before the milestones in August . GL
ETON = BREEEEEEEEEEEEEEEEEEEEEAAAAAAAAAAAAAAAAAAAAK OUUUUUUUUUUUUUUUUUUUT
MC $96 M--3x FDA DECISIONS this year including a Orphan Drug ,LOW FLOAT =CHEAPEST and MOST attractive FDA Gem in 2020 a potential 10 Bagger . Could run to 8$ even before the milestones in August . GL